Histamine H4 receptor ligands: Future applications and state of art

Chemical Biology and Drug Design

Volumn 85, Issue 4, 2015, Pages 461-480

  Corrêa, Michelle Fidelis ^a   Fernandes, João Paulo Dos Santos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antihistamines; H4 receptor ligands; molecular modeling; QSAR; structure activity relationships

Indexed keywords

1 (5 CHLORO 2 BENZIMIDAZOLYLCARBONYL) 4 METHYLPIPERAZINE; 1 (5 CHLORO 2 INDOLYLCARBONYL) 4 METHYLPIPERAZINE; 4 METHYLHISTAMINE; BENZIMIDAZOLE DERIVATIVE; CIMETIDINE; CIPROXIFAN; CLOBENPROPIT; DIMAPRIT; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H2 RECEPTOR; HISTAMINE H3 RECEPTOR; HISTAMINE H4 RECEPTOR; IMETIT; IMIDAZOLE; LIGAND; QUINAZOLINE DERIVATIVE; QUINOXALINE; RHODOPSIN; UNCLASSIFIED DRUG; VUF 10214; 2-AMINOPYRIMIDINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE RECEPTOR; HRH4 PROTEIN, HUMAN; IMIDAZOLE DERIVATIVE; INDOLE DERIVATIVE; INDOLE-5-CARBOXAMIDE; PYRIMIDINE DERIVATIVE; QUINOXALINE DERIVATIVE;

CLINICAL TRIAL (TOPIC); CRYSTAL STRUCTURE; HUMAN; MOLECULAR MODEL; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; IMMUNOLOGY; INFLAMMATION; PROCEDURES; STRUCTURE ACTIVITY RELATION;

ANIMALS; DRUG DISCOVERY; HUMANS; IMIDAZOLES; INDOLES; INFLAMMATION; LIGANDS; MODELS, MOLECULAR; PYRIMIDINES; QUINAZOLINES; QUINOXALINES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84924366023     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/cbdd.12431     Document Type: Review

References (106)

1. Hilal-Dandan R., Brunton L., editors. (2013) Goodman & Gilman Manual of Pharmacology and Therapeutics, 2nd edn. New York, USA: McGraw-Hill.
2. Passani M.B., Blandina P., (2011) Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol Sci; 32: 242-249.
3. 1R. J Mol Graph Model; 39: 1-12.
4. Parsons M.E., Ganellin C.R., (2006) Histamine and its receptors. Br J Pharmacol; 147 (Suppl. 1): S127-S135.
5. 4 receptor in dermal and articular tissues. Life Sci; 92: 108-113.
6. Nelson W.L., (2012) Antihistamines and related antiallergic and antiulcer agents. In:, Lemke T.L., Williams D.A., editors. Foye's Principles of Medicinal Chemistry, 7th edn. Philadelphia, PA, USA: Lippincott Williams & Wilkins; p. 1045-1072.
7. 3 receptor antagonists with robust wake-promoting activity. Bioorg Med Chem Lett; 21: 6362-6365.
8. 3 receptor antagonists reach out for the clinic. Drug Discov Today; 10: 1613-1627.
9. 4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov; 7: 41-53.
10. 4 receptors in the central nervous system of human and rat. Brain Res; 1250: 41-48.
11. 4 receptor inverse agonists. Bioorg Med Chem Lett; 20: 2516-2519.
12. 4 receptor in inflammatory skin diseases and pruritus. Front. Biosci; 3: 985-994.
13. 4 receptor antagonists based on the pyrido[3,2-d]pyrimidine scaffold: comparison of hERG binding and target residence time with PF-3893787. Bioorg Med Chem Lett; 23: 2663-2670.
14. Oda T., Morikawa N., Saito Y., Masuho Y., Matsumoto S., (2000) Molecular clonning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem; 275: 36781-36786.
15. 4 receptor. Br J Pharmacol; 140: 1117-1127.
16. Leurs R., Smit M.J., Timmerman H., (1995) Molecular pharmacological aspects of histamine receptors. Pharmacol Ther; 66: 413-463.
17. 1-receptor antagonists with immunomodulating activities: potential use for modulating T helper type 1 (Th1)/Th2 cytokine imbalance and inflammatory responses in allergic diseases. Clin Exp Immunol; 157: 27-34.
18. Bighetti A.E., Antônio M.A., Carvalho J.E., (2002) Regulação e Modulação da Secreção Gástrica. Rev Ciênc Med; 11: 55-60.
19. Procopiou P.A., Browning C., Gore P.M., Lynn S.M., Richards S.A., Slack R.J., Sollis S.L., (2012) Bioorg Med Chem; 20: 6097-6108.
20. 3) of histamine receptor. Nature; 302: 832-837.
21. 4 receptor ligands. Drug Discov Today; 14: 745-753.
22. 3 receptor drugs. Nat Rev Drug Discov; 4: 107-120.
23. 3 receptor antagonist. Biochem Pharmacol; 68: 933-945.
24. 3-receptor antagonists of the 2-aminobenzimidazole series. Bioorg Med Chem; 14: 1413-1424.
25. 3 receptor ligands incorporating antiepileptic moieties. Eur J Med Chem; 77: 269-279.
26. 3 receptor ligands for improved drug-likeness. Bioorg Med Chem Lett; 24: 2236-2239.
27. 3 receptor antagonists/inverse agonists: a patent review (2010-present). Expert Opin Ther Pat; 24: 89-111.
28. 4) expressed in bone marrow. Mol Pharmacol; 59: 420-426.
29. Morse K.L., Behan J., Laz T.M., West R.E., Greenfeder S.A., Anthes J.C., Umland S., et al,. (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther; 296: 1058-1066.
30. Nguyen T., Shapiro D.A., George S.R., Setola V., Lee D.K., Cheng R., Rauser L., Lunch K.R., Roth B.L., O'Dowd B.F., (2001) Discovery of a novel member of the histamine receptor family. Mol Pharmacol; 59: 427-433.
31. Zhu Y., Michalovich D., Wu H., Tan K.B., Dytko G.M., Mannan I.J., Boyce R., et al,. (2001) Cloning, expression, and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol; 59: 434-441.
32. 4 receptor as a new therapeutic target for inflammation. Trends Pharmacol Sci; 26: 462-469.
33. 4 receptor joins the club of 7 transmembrane domain receptors exhibiting functional selectivity. Mol Pharmacol; 79: 631-638.
34. 4 receptor. Chem Rev; 111: 7121-7156.
35. 4 receptor. Mol Pharmacol; 62: 38-47.
36. 4 receptor using mutational analysis, homology modeling, and ab Initio calculations. J Chem Inf Model; 48: 1455-1463.
37. 4 receptors. J Pharmacol Exp Ther; 327: 88-96.
38. 4 receptors ligands. J Med Chem; 51: 6571-6580.
39. 4R species variants. Mol Pharmacol; 77: 734-743.
40. 4 receptor is functionally expressed on neurons in the mammalian CNS. Br J Pharmacol; 157: 55-63.
41. Glatzer F., Gschwandtner M., Mommert S., Werfel T., Gutzmer R., (2013) Keratinocytes from patients with atopic dermatitis express high levels of histamine 4 receptor which mediate histamine induced proliferation. J Invest Dermatol; 133 (Suppl. 1): S25.
42. 4 receptor on human eosinophils. Role in eosinophil chemotaxis. J Recept Signal Transduct Res; 22: 431-448.
43. 4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation. Br J Pharmacol; 142: 161-171.
44. Thurmond R.L., Desai P.J., Dunford P.J., Fung-Leung W.P., Hofstra C.L., Jiang W., Nguyen S., Riley J.P., Sun S., Williams K.N., Edwards J.P., Karlsson L., (2004) A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J Pharmacol Exp Ther; 309: 404-413.
45. 4 receptor mediates allergic airway inflammation by regulating the activation of CD4 + T cells. J Immunol; 176: 7062-7070.
46. Varga C., Horvath K., Berko A., Thurmond R.L., Dunford P.J., Whittle B.J., (2005) Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. Eur J Pharmacol; 522: 130-138.
47. 4 receptor antagonism exhibits anti-nociceptive effects in inflammatory and neuropathic pain models in rats. Pharmacol Biochem Behav; 95: 41-50.
48. 4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. J Allergy Clin Immunol; 119: 176-183.
49. 4-receptor antagonists JNJ7777120 and VUF6002 in a rat model of carrageenan-induced acute inflammation. Eur J Pharmacol; 563: 240-244.
50. 4 receptor in immune and inflammatory disorders. Br J Pharmacol; 157: 24-33.
51. 4-receptor. Biochemistry; 48: 1424-1438.
52. 4-receptor. Mol Pharmacol; 76: 1019-1030.
53. 4 receptor ligands. J Pharmacol Exp Ther; 334: 513-521.
54. 4 receptor ligands as potential modulators of inflammatory and allergic responses. Antiinflamm Antiallergy Agents Med Chem; 5: 307-322.
55. 4 receptor agonist. J Pharmacol Exp Ther; 314: 1310-1321.
56. 4-receptor agonist: (-)-2-cyano-1-methyl-3-{(2R,5R)-5-[1H-imidazol-4(5)-yl]tetrahydrofuran-2-yl}methylguanidine. J Med Chem; 46: 3162-3165.
57. 4 receptor agonist. J Med Chem; 49: 6650-6651.
58. Lim H.D., Istyastono E.P., van De Stolpe A., Romeo G., Gobbi S., Schepers M., Lahaye R., Menge W.M.B.P., Zuiderveld O.P., Jongejan A., Smits R.A., Bakker R.A., Haaksma E.E.J., Leurs R., De Esch I.J.P., (2009) Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies. Bioorg Med Chem; 17: 3987-3994.
59. 3 antagonists. Bioorg Med Chem; 13: 5647-5657.
60. 4 receptor: linking ligand-based three-dimensional quantitative structure-activity relationship (3D-QSAR) models to in silico guided receptor mutagenesis studies. J Med Chem; 54: 8136-8147.
61. G-substituent. J Med Chem; 52: 2623-2627.
62. 4 receptor agonists. J Med Chem; 52: 6297-6313.
63. 4 receptor activity of conformationally restricted cyanoguanidines related to UR-PI376. Arch Pharm; 344: 775-785.
64. Geyer R., Igel P., Kaske M., Elz S., Buschauer A., (2014) Synthesis, SAR and selectivity of 2-acyl- and 2-cyano-1-hetarylalkyl-guanidines at the four histamine receptor subtypes: a bioisosteric approach. Medchemcomm; 5: 72-81.
65. 4 receptor ligands. Bioorg Med Chem Lett; 18: 1076-1082.
66. 4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorg Med Chem Lett; 19: 6682-6685.
67. 3 subtype selectivity. J Med Chem; 54: 1693-1703.
68. 4 receptor ligands. Bioorg Med Chem; 19: 2850-2858.
69. 4 receptor antagonists. J Med Chem; 46: 3957-3960.
70. 4 antagonists. J Med Chem; 48: 8289-8298.
71. 4 receptor ligands. Eur J Med Chem; 54: 660-668.
72. 4 receptor antagonists. Bioorg Med Chem Lett; 14: 5251-5256.
73. 4 receptor antagonist JNJ7777120 in a murine model of acute skin inflammation. Exp Dermatol; 21: 32-37.
74. 4 receptor antagonism reduces hapten-induced scratching behaviour but not inflammation. Exp Dermatol; 18: 57-63.
75. 4 receptor antagonists in a dog model of acute atopic dermatitis. Exp Dermatol; 20: 577-581.
76. 4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice. Allergy; 67: 1014-1022.
77. 4 receptor. JNJ7777120 recruits β-arrestin without activating G-proteins. Mol Pharmacol; 79: 1424-1438.
78. 4 receptor ligands. Bioorg Med Chem Lett; 16: 6043-6048.
79. 4 receptor. J Receptor Ligand Channel Res; 3: 37-49.
80. 4 receptor ligands in the group of 4-methylpiperazino amide derivatives. Inflamm Res; 59 (Suppl. 2): S243-S245.
81. 4 receptor antagonist. Bioorg Med Chem Lett; 21: 6596-6602.
82. 4 receptor antagonists. Bioorg Med Chem Lett; 22: 1156-1159.
83. 4 receptor-ligands with anti-inflammatory properties in vivo. J Med Chem; 51: 2457-2467.
84. 4 receptor inverse agonists using a scaffold hopping approach. J Med Chem; 51: 7855-7865.
85. 4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. J Med Chem; 51: 6547-6557.
86. 4 receptor inverse agonists. J Med Chem; 53: 2390-2400.
87. 4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. J Med Chem; 51: 7094-7098.
88. 4 receptor ligands-Scaffold optimization and pharmacological characterization. Bioorg Med Chem; 17: 7186-7196.
89. Topliss J.G., (1972) Utilization of operational schemes for analog synthesis in drug design. J Med Chem; 15: 1006-1011.
90. 4 receptor antagonists: effects of substitution about the rigidifying ring. Bioorg Med Chem Lett; 20: 1900-1904.
91. Savall B.M., Gomez L., Chavez F., Curtis M., Meduna S.P., Kearney A., Dunford P., Cowden J., Thurmond R.L., Grice C., Edwards J.P., (2011) Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorg Med Chem Lett; 21: 6577-6581.
92. 4 receptor a new drug target for allergies and asthma? Front Biosci (Elite Ed); E5: 178-187.
93. 4 receptor antagonists, fragment optimization and analysis of binding kinetics. Bioorg Med Chem Lett; 22: 461-467.
94. 4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold. Bioorg Med Chem Lett; 23: 132-137.
95. Savall B.M., Chavez F., Tays K., Dunford P.J., Cowden J.M., Hack M.D., Wolin R.L., Thurmond R.L., Edwards J.P., (2014) Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H receptor antagonists. J Med Chem; 57: 2429-2439.
96. Thurmond R.L., Chen B., Dunford P.J., Greenspan A.J., Karlsson L., La D., Ward P., Xu X.L., (2014) Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979. J Pharmacol Exp Ther; 349: 176-184.
97. 4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. J Med Chem; 49: 4512-4516.
98. 4 receptor-ligand binding modes. Medchemcomm; 4: 193-204.
99. 4 receptor. Eur J Med Chem; 43: 1059-1070.
100. 4 receptor ligands by large-scale structure-based virtual screening. J Med Chem; 51: 3145-3153.
101. 4R antagonists using 3D-QSAR, molecular docking and molecular dynamics. J Mol Model; 18: 991-1001.
102. 3A. Bioorg Med Chem Lett; 21: 5460-5464.
103. 4 receptor antagonists through structure-based virtual screening strategies. Chem Biol Drug Des; 79: 749-759.
104. 1 receptor complex with doxepin. Nature; 475: 65-70.
105. 4 receptor ligands. J Enzyme Inhib Med Chem; 26: 412-421.
106. 4 receptor antagonists. J Mol Model; 17: 921-928.